Rapp Richard C, Xu Jiangmin, Carr Carey A, Lane D Tim, Wang Jichuan, Carlson Robert
Center for Interventions, Treatment, and Addictions Research (CITAR), Boonshoft School of Medicine, Wright State University, 3640 Colonel Glenn Highway, Dayton, OH 45435, USA.
J Subst Abuse Treat. 2006 Apr;30(3):227-35. doi: 10.1016/j.jsat.2006.01.002.
The 59-item Barriers to Treatment Inventory (BTI) was administered to 312 substance abusers at a centralized intake unit following assessment but before treatment entry to assess their views on barriers to treatment. Factor analysis identified 25 items in 7 well-defined latent constructs: Absence of Problem, Negative Social Support, Fear of Treatment, Privacy Concerns, Time Conflict, Poor Treatment Availability, and Admission Difficulty. The factorial structure of the barriers is consistent with the findings of other studies that asked substance abusers about barriers to treatment and is conceptually compatible with Andersen's model of health care utilization. Factors were moderately to highly correlated, suggesting that they interact with one another. Selected characteristics were generally not predictive of barrier factors. Overall, results indicate that the BTI has good content validity and is a reliable instrument for assessing barriers to drug treatment. The potential utility of the BTI in assessment settings is discussed.
在一个集中接收单元，对312名药物滥用者在评估后但在进入治疗前进行了59项治疗障碍量表（BTI）的施测，以评估他们对治疗障碍的看法。因子分析在7个明确的潜在结构中确定了25个项目：无问题、消极社会支持、对治疗的恐惧、隐私担忧、时间冲突、治疗可及性差和入院困难。这些障碍的因子结构与其他询问药物滥用者治疗障碍的研究结果一致，并且在概念上与安德森的医疗保健利用模型相符。各因子之间存在中度到高度的相关性，表明它们相互作用。选定的特征通常不能预测障碍因素。总体而言，结果表明BTI具有良好的内容效度，是评估药物治疗障碍的可靠工具。文中还讨论了BTI在评估环境中的潜在效用。
